Purinergic signalling in autoimmunity: A role for the P2X7R in systemic lupus erythematosus?

Sugiyama, 1969, Calcium-dependent histamine release by ATP from isolated rat mast cells, Jpn J Pharmacol, 19, 175, 10.1254/jjp.19.175 Dahlquist, 1970, Further observations on ATP-induced histamine release from rat mast cells, Acta Pharmacol Toxicol (Copenh), 28, 43 Dahlquist, 1974, Increased permeability of the rat mast cell membrane to sodium and potassium caused by extracellular ATP and its relationship to histamine release, Int Arch Allergy Appl Immunol, 46, 655, 10.1159/000231167 Cockcroft, 1979, ATP induces nucleotide permeability in rat mast cells, Nature, 279, 541, 10.1038/279541a0 Burnstock, 1972, A comparison of the excitatory and inhibitory effects of non-adrenergic, non-cholinergic nerve stimulation and exogenously applied ATP on a variety of smooth muscle preparations from different vertebrate species, Br J Pharmacol, 46, 234, 10.1111/j.1476-5381.1972.tb06868.x Webb, 1993, Cloning and functional expression of a brain G-protein-coupled ATP receptor, FEBS Lett, 324, 219, 10.1016/0014-5793(93)81397-I Burnstock, 2007, Physiology and pathophysiology of purinergic neurotransmission, Physiol Rev, 87, 659, 10.1152/physrev.00043.2006 Khakh, 2009, The double life of ATP, Sci Am, 301, 10.1038/scientificamerican1209-84 Agboh, 2004, Functional characterization of a P2X receptor from Schistosoma mansoni, J Biol Chem, 279, 41650, 10.1074/jbc.M408203200 Fountain, 2007, An intracellular P2X receptor required for osmoregulation in Dictyostelium discoideum, Nature, 448, 200, 10.1038/nature05926 Kucenas, 2003, Molecular characterization of the zebrafish P2X receptor subunit gene family, Neuroscience, 121, 935, 10.1016/S0306-4522(03)00566-9 North, 2002, Molecular physiology of P2X receptors, Physiol Rev, 82, 1013, 10.1152/physrev.00015.2002 Wang, 2013, Autophagy-dependent ATP release from dying cells via lysosomal exocytosis, Autophagy, 9, 1624, 10.4161/auto.25873 Sneddon, 1984, Pharmacological evidence that adenosine triphosphate and noradrenaline are co-transmitters in the Guinea-pig vas deferens, J Physiol, 347, 561, 10.1113/jphysiol.1984.sp015083 Cantiello, 2001, Electrodiffusional ATP movement through CFTR and other ABC transporters, Pflugers Arch, 443, S22 Dahl, 2015, ATP release through pannexon channels, Philos Trans R Soc Lond B Biol Sci, 370, 20140191, 10.1098/rstb.2014.0191 Evans, 2006, The gap junction cellular internet: connexin hemichannels enter the signalling limelight, Biochem J, 397, 1, 10.1042/BJ20060175 Pellegatti, 2005, A novel recombinant plasma membrane-targeted luciferase reveals a new pathway for ATP secretion, Mol Biol Cell, 16, 3659, 10.1091/mbc.e05-03-0222 Suadicani, 2006, P2X7 receptors mediate ATP release and amplification of astrocytic intercellular Ca2+ signaling, J Neurosci, 26, 1378, 10.1523/JNEUROSCI.3902-05.2006 Abbracchio, 2009, Purinergic signalling in the nervous system: an overview, Trends Neurosci, 32, 19, 10.1016/j.tins.2008.10.001 Jacobson, 2015, Nucleotides acting at P2Y receptors: connecting structure and function, Mol Pharmacol, 88, 220, 10.1124/mol.114.095711 Kaczmarek-Hajek, 2012, Molecular and functional properties of P2X receptors–recent progress and persisting challenges, Purinergic Signal, 8, 375, 10.1007/s11302-012-9314-7 Dubyak, 2007, Go it alone no more–P2X7 joins the society of heteromeric ATP-gated receptor channels, Mol Pharmacol, 72, 1402, 10.1124/mol.107.042077 Guo, 2007, Evidence for functional P2X4/P2X7 heteromeric receptors, Mol Pharmacol, 72, 1447, 10.1124/mol.107.035980 Nicke, 2008, Homotrimeric complexes are the dominant assembly state of native P2X7 subunits, Biochem Biophys Res Commun, 377, 803, 10.1016/j.bbrc.2008.10.042 Clyne, 2002, Mutational analysis of the conserved cysteines of the rat P2X2 purinoceptor, J Neurosci, 22, 3873, 10.1523/JNEUROSCI.22-10-03873.2002 Liu, 2009, Identification of the amino acid residues in the extracellular domain of rat P2X(7) receptor involved in functional inhibition by acidic pH, Br J Pharmacol, 156, 135, 10.1111/j.1476-5381.2008.00002.x Jarvis, 2009, ATP-gated P2X cation-channels, Neuropharmacology, 56, 208, 10.1016/j.neuropharm.2008.06.067 Khakh, 2006, P2X receptors as cell-surface ATP sensors in health and disease, Nature, 442, 527, 10.1038/nature04886 Jiang, 2003, Subunit arrangement in P2X receptors, J Neurosci, 23, 8903, 10.1523/JNEUROSCI.23-26-08903.2003 Young, 2010, P2X receptors: dawn of the post-structure era, Trends Biochem Sci, 35, 83, 10.1016/j.tibs.2009.09.006 Kubick, 2011, The effect of anions on the human P2X7 receptor, Biochim Biophys Acta, 1808, 2913, 10.1016/j.bbamem.2011.08.017 Egan, 2004, Contribution of calcium ions to P2X channel responses, J Neurosci, 24, 3413, 10.1523/JNEUROSCI.5429-03.2004 Samways, 2007, Acidic amino acids impart enhanced Ca2+ permeability and flux in two members of the ATP-gated P2X receptor family, J Gen Physiol, 129, 245, 10.1085/jgp.200609677 Cockcroft, 1980, The ATP4- receptor of rat mast cells, Biochem J, 188, 789, 10.1042/bj1880789 Steinberg, 1988, A prelysosomal compartment sequesters membrane-impermeant fluorescent dyes from the cytoplasmic matrix of J774 macrophages, J Cell Biol, 107, 887, 10.1083/jcb.107.3.887 Di Virgilio, 1988, Inhibitors of membrane transport system for organic anions block fura-2 excretion from PC12 and N2A cells, Biochem J, 256, 959, 10.1042/bj2560959 Surprenant, 1996, The cytolytic P2Z receptor for extracellular ATP identified as a P2X receptor (P2X7), Science, 272, 735, 10.1126/science.272.5262.735 Wiley, 1992, The ATP4- receptor-operated ion channel of human lymphocytes: inhibition of ion fluxes by amiloride analogs and by extracellular sodium ions, Arch Biochem Biophys, 292, 411, 10.1016/0003-9861(92)90010-T Faria, 2010, Large-conductance channel formation mediated by P2X7 receptor activation is regulated through distinct intracellular signaling pathways in peritoneal macrophages and 2BH4 cells, Naunyn Schmiedebergs Arch Pharmacol, 382, 73, 10.1007/s00210-010-0523-8 Khakh, 1999, Neuronal P2X transmitter-gated cation channels change their ion selectivity in seconds, Nat Neurosci, 2, 322, 10.1038/7233 Virginio, 1999, Pore dilation of neuronal P2X receptor channels, Nat Neurosci, 2, 315, 10.1038/7225 Li, 2015, Physical basis of apparent pore dilation of ATP-activated P2X receptor channels, Nat Neurosci, 18, 1577, 10.1038/nn.4120 Mulryan, 2000, Reduced vas deferens contraction and male infertility in mice lacking P2X1 receptors, Nature, 403, 86, 10.1038/47495 Khakh, 2003, ATP modulation of excitatory synapses onto interneurons, J Neurosci, 23, 7426, 10.1523/JNEUROSCI.23-19-07426.2003 Zhong, 2003, Bladder and cutaneous sensory neurons of the rat express different functional P2X receptors, Neuroscience, 120, 667, 10.1016/S0306-4522(03)00243-4 Bours, 2006, Adenosine 5′-triphosphate and adenosine as endogenous signaling molecules in immunity and inflammation, Pharmacol Ther, 112, 358, 10.1016/j.pharmthera.2005.04.013 Labasi, 2002, Absence of the P2X7 receptor alters leukocyte function and attenuates an inflammatory response, J Immunol, 168, 6436, 10.4049/jimmunol.168.12.6436 Woods, 2016, Purinergic receptors as potential therapeutic targets in Alzheimer's disease, Neuropharmacology, 104, 169, 10.1016/j.neuropharm.2015.10.031 Burnstock, 2013, Purinergic signalling and cancer, Purinergic Signal, 9, 491, 10.1007/s11302-013-9372-5 Toulme, 2010, On the role of ATP-gated P2X receptors in acute, inflammatory and neuropathic pain Barclay, 2002, Functional downregulation of P2X3 receptor subunit in rat sensory neurons reveals a significant role in chronic neuropathic and inflammatory pain, J Neurosci, 22, 8139, 10.1523/JNEUROSCI.22-18-08139.2002 Cockayne, 2005, P2X2 knockout mice and P2X2/P2X3 double knockout mice reveal a role for the P2X2 receptor subunit in mediating multiple sensory effects of ATP, J Physiol, 567, 621, 10.1113/jphysiol.2005.088435 Ke, 2003, Deletion of the P2X7 nucleotide receptor reveals its regulatory roles in bone formation and resorption, Mol Endocrinol, 17, 1356, 10.1210/me.2003-0021 Rossato, 2001, Extracellular ATP stimulates estradiol secretion in rat Sertoli cells in vitro: modulation by external sodium, Mol Cell Endocrinol, 178, 181, 10.1016/S0303-7207(01)00426-9 Yamamoto, 2006, Impaired flow-dependent control of vascular tone and remodeling in P2X4-deficient mice, Nat Med, 12, 133, 10.1038/nm1338 Hechler, 2015, Purinergic receptors in thrombosis and inflammation, Arterioscler Thromb Vasc Biol, 35, 2307, 10.1161/ATVBAHA.115.303395 Tsuda, 2003, P2X4 receptors induced in spinal microglia gate tactile allodynia after nerve injury, Nature, 424, 778, 10.1038/nature01786 Schwab, 2005, Spinal cord injury induces early and persistent lesional P2X4 receptor expression, J Neuroimmunol, 163, 185, 10.1016/j.jneuroim.2005.02.016 Cavaliere, 2003, Up-regulation of P2X2, P2X4 receptor and ischemic cell death: prevention by P2 antagonists, Neuroscience, 120, 85, 10.1016/S0306-4522(03)00228-8 Guo, 2005, Lesional accumulation of P2X(4) receptor(+) macrophages in rat CNS during experimental autoimmune encephalomyelitis, Neuroscience, 134, 199, 10.1016/j.neuroscience.2005.04.026 Di Virgilio, 2015, Purinergic signaling in the immune system, Auton Neurosci, 191, 117, 10.1016/j.autneu.2015.04.011 Cattaneo, 2015, P2Y12 receptors: structure and function, J Thromb Haemost, 13, S10, 10.1111/jth.12952 McInnes, 2014, Targeting the P2X7 receptor in rheumatoid arthritis: biological rationale for P2X7 antagonism, Clin Exp Rheumatol, 32, 878 Marques-da-Silva, 2011, Colchicine inhibits cationic dye uptake induced by ATP in P2X2 and P2X7 receptor-expressing cells: implications for its therapeutic action, Br J Pharmacol, 163, 912, 10.1111/j.1476-5381.2011.01254.x Amaral, 2014, Pulmonary infection with hypervirulent Mycobacteria reveals a crucial role for the P2X7 receptor in aggressive forms of tuberculosis, PLoS Pathog, 10, e1004188, 10.1371/journal.ppat.1004188 Coutinho-Silva, 2003, Inhibition of chlamydial infectious activity due to P2X7R-dependent phospholipase D activation, Immunity, 19, 403, 10.1016/S1074-7613(03)00235-8 Surprenant, 2009, Signaling at purinergic P2X receptors, Annu Rev Physiol, 71, 333, 10.1146/annurev.physiol.70.113006.100630 Kawate, 2009, Crystal structure of the ATP-gated P2X(4) ion channel in the closed state, Nature, 460, 592, 10.1038/nature08198 Hattori, 2012, Molecular mechanism of ATP binding and ion channel activation in P2X receptors, Nature, 485, 207, 10.1038/nature11010 Pizzo, 1991, Extracellular ATP causes lysis of mouse thymocytes and activates a plasma membrane ion channel, Biochem J, 274, 139, 10.1042/bj2740139 Gargett, 1997, ATP, a partial agonist for the P2Z receptor of human lymphocytes, Br J Pharmacol, 122, 911, 10.1038/sj.bjp.0701447 Gomperts, 1980, Early events in the activation of Ca2+ dependent secretion: studies with rat peritoneal mast cells, J Physiol (Paris), 76, 383 Pelegrin, 2011, Many ways to dilate the P2X7 receptor pore, Br J Pharmacol, 163, 908, 10.1111/j.1476-5381.2011.01325.x Coddou, 2011, Activation and regulation of purinergic P2X receptor channels, Pharmacol Rev, 63, 641, 10.1124/pr.110.003129 Kim, 2001, Differential assembly of rat purinergic P2X7 receptor in immune cells of the brain and periphery, J Biol Chem, 276, 23262, 10.1074/jbc.M102253200 Ferrari, 2007, Modulation of P2X7 receptor functions by polymyxin B: crucial role of the hydrophobic tail of the antibiotic molecule, Br J Pharmacol, 150, 445, 10.1038/sj.bjp.0706994 Ferrari, 2004, The antibiotic polymyxin B modulates P2X7 receptor function, J Immunol, 173, 4652, 10.4049/jimmunol.173.7.4652 Baroja-Mazo, 2013, The participation of plasma membrane hemichannels to purinergic signaling, Biochim Biophys Acta, 1828, 79, 10.1016/j.bbamem.2012.01.002 Bartlett, 2014, The P2X7 receptor channel: recent developments and the use of P2X7 antagonists in models of disease, Pharmacol Rev, 66, 638, 10.1124/pr.113.008003 Cheewatrakoolpong, 2005, Identification and characterization of splice variants of the human P2X7 ATP channel, Biochem Biophys Res Commun, 332, 17, 10.1016/j.bbrc.2005.04.087 Wiley, 2011, The human P2X7 receptor and its role in innate immunity, Tissue Antigens, 78, 321, 10.1111/j.1399-0039.2011.01780.x Cabrini, 2005, A His-155 to Tyr polymorphism confers gain-of-function to the human P2X7 receptor of human leukemic lymphocytes, J Immunol, 175, 82, 10.4049/jimmunol.175.1.82 Dardano, 2009, 1513A>C polymorphism in the P2X7 receptor gene in patients with papillary thyroid cancer: correlation with histological variants and clinical parameters, J Clin Endocrinol Metab, 94, 695, 10.1210/jc.2008-1322 Ohlendorff, 2007, Single nucleotide polymorphisms in the P2X7 gene are associated to fracture risk and to effect of estrogen treatment, Pharmacogenet Genomics, 17, 555, 10.1097/FPC.0b013e3280951625 Mrazek, 2010, Functional variants of the P2RX7 gene, aseptic osteolysis, and revision of the total hip arthroplasty: a preliminary study, Hum Immunol, 71, 201, 10.1016/j.humimm.2009.10.013 Jorgensen, 2015, The role of P2X receptors in bone biology, Curr Med Chem, 22, 902, 10.2174/0929867321666141215094749 Shemon, 2006, A Thr357 to Ser polymorphism in homozygous and compound heterozygous subjects causes absent or reduced P2X7 function and impairs ATP-induced mycobacterial killing by macrophages, J Biol Chem, 281, 2079, 10.1074/jbc.M507816200 Xiao, 2010, Metaanalysis of P2X7 gene polymorphisms and tuberculosis susceptibility, FEMS Immunol Med Microbiol, 60, 165, 10.1111/j.1574-695X.2010.00735.x Adinolfi, 2009, Expression of the P2X7 receptor increases the Ca2+ content of the endoplasmic reticulum, activates NFATc1, and protects from apoptosis, J Biol Chem, 284, 10120, 10.1074/jbc.M805805200 Adinolfi, 2010, Trophic activity of a naturally occurring truncated isoform of the P2X7 receptor, FASEB J, 24, 3393, 10.1096/fj.09-153601 Giuliani, 2014, Trophic activity of human P2X7 receptor isoforms A and B in osteosarcoma, PLoS One, 9, e107224, 10.1371/journal.pone.0107224 Atkinson, 2002, An ATP-gated ion channel at the cell nucleus, Nature, 420, 42, 10.1038/420042a Gonnord, 2009, Palmitoylation of the P2X7 receptor, an ATP-gated channel, controls its expression and association with lipid rafts, FASEB J, 23, 795, 10.1096/fj.08-114637 Ferrari, 1997, Extracellular ATP triggers IL-1 beta release by activating the purinergic P2Z receptor of human macrophages, J Immunol, 159, 1451 Mariathasan, 2006, Cryopyrin activates the inflammasome in response to toxins and ATP, Nature, 440, 228, 10.1038/nature04515 Di Virgilio, 2007, Liaisons dangereuses: P2X(7) and the inflammasome, Trends Pharmacol Sci, 28, 465, 10.1016/j.tips.2007.07.002 Piccini, 2008, ATP is released by monocytes stimulated with pathogen-sensing receptor ligands and induces IL-1beta and IL-18 secretion in an autocrine way, Proc Natl Acad Sci U S A, 105, 8067, 10.1073/pnas.0709684105 Di Virgilio, 1996, P2 purinoceptors in the immune system, Ciba Found Symp, 198, 290 Munoz-Planillo, 2013, K(+) efflux is the common trigger of NLRP3 inflammasome activation by bacterial toxins and particulate matter, Immunity, 38, 1142, 10.1016/j.immuni.2013.05.016 Cruz, 2007, ATP activates a reactive oxygen species-dependent oxidative stress response and secretion of proinflammatory cytokines in macrophages, J Biol Chem, 282, 2871, 10.1074/jbc.M608083200 Sperlagh, 1998, ATP released by LPS increases nitric oxide production in raw 264.7 macrophage cell line via P2Z/P2X7 receptors, Neurochem Int, 33, 209, 10.1016/S0197-0186(98)00025-4 Franceschini, 2015, The P2X7 receptor directly interacts with the NLRP3 inflammasome scaffold protein, FASEB J, 29, 2450, 10.1096/fj.14-268714 Ferrari, 2006, The P2X7 receptor: a key player in IL-1 processing and release, J Immunol, 176, 3877, 10.4049/jimmunol.176.7.3877 Ferrari, 1997, Extracellular ATP activates transcription factor NF-kappaB through the P2Z purinoreceptor by selectively targeting NF-kappaB p65, J Cell Biol, 139, 1635, 10.1083/jcb.139.7.1635 Liu, 2011, P2X7 receptor positively regulates MyD88-dependent NF-kappaB activation, Cytokine, 55, 229, 10.1016/j.cyto.2011.05.003 Chang, 2015, Protective effect of apigenin on Freund's complete adjuvant-induced arthritis in rats via inhibiting P2X7/NF-kappaB pathway, Chem Biol Interact, 236, 41, 10.1016/j.cbi.2015.04.021 Tafani, 2014, Bridging hypoxia, inflammation and estrogen receptors in thyroid cancer progression, Biomed Pharmacother, 68, 1, 10.1016/j.biopha.2013.10.013 Adinolfi, 2005, Basal activation of the P2X7 ATP receptor elevates mitochondrial calcium and potential, increases cellular ATP levels, and promotes serum-independent growth, Mol Biol Cell, 16, 3260, 10.1091/mbc.e04-11-1025 Budagian, 2003, Signaling through P2X7 receptor in human T cells involves p56lck, MAP kinases, and transcription factors AP-1 and NF-kappa B, J Biol Chem, 278, 1549, 10.1074/jbc.M206383200 Amoroso, 2015, The P2X7 receptor is a key modulator of the PI3K/GSK3beta/VEGF signaling network: evidence in experimental neuroblastoma, Oncogene, 34, 5240, 10.1038/onc.2014.444 Adinolfi, 2012, Expression of P2X7 receptor increases in vivo tumor growth, Cancer Res, 72, 2957, 10.1158/0008-5472.CAN-11-1947 Jelassi, 2011, P2X(7) receptor activation enhances SK3 channels- and cystein cathepsin-dependent cancer cells invasiveness, Oncogene, 30, 2108, 10.1038/onc.2010.593 Jelassi, 2013, Anthraquinone emodin inhibits human cancer cell invasiveness by antagonizing P2X7 receptors, Carcinogenesis, 34, 1487, 10.1093/carcin/bgt099 Di Virgilio, 2009, P2X(7): a growth-promoting receptor-implications for cancer, Purinergic Signal, 5, 251, 10.1007/s11302-009-9145-3 Adinolfi, 2015, Accelerated tumor progression in mice lacking the ATP receptor P2X7, Cancer Res, 75, 635, 10.1158/0008-5472.CAN-14-1259 Kusner, 2001, ATP stimulates human macrophages to kill intracellular virulent Mycobacterium tuberculosis via calcium-dependent phagosome-lysosome fusion, J Immunol, 167, 3308, 10.4049/jimmunol.167.6.3308 Pizzirani, 2007, Stimulation of P2 receptors causes release of IL-1beta-loaded microvesicles from human dendritic cells, Blood, 109, 3856, 10.1182/blood-2005-06-031377 Bianco, 2005, Astrocyte-derived ATP induces vesicle shedding and IL-1 beta release from microglia, J Immunol, 174, 7268, 10.4049/jimmunol.174.11.7268 Baroja-Mazo, 2014, The NLRP3 inflammasome is released as a particulate danger signal that amplifies the inflammatory response, Nat Immunol, 15, 738, 10.1038/ni.2919 Thomas, 2010, Activation of macrophages by P2X7-induced microvesicles from myeloid cells is mediated by phospholipids and is partially dependent on TLR4, J Immunol, 185, 3740, 10.4049/jimmunol.1001231 Chiozzi, 1997, Spontaneous cell fusion in macrophage cultures expressing high levels of the P2Z/P2X7 receptor, J Cell Biol, 138, 697, 10.1083/jcb.138.3.697 Lemaire, 2006, Involvement of the purinergic P2X7 receptor in the formation of multinucleated giant cells, J Immunol, 177, 7257, 10.4049/jimmunol.177.10.7257 Lemaire, 2011, The P2X7 receptor and Pannexin-1 are both required for the promotion of multinucleated macrophages by the inflammatory cytokine GM-CSF, J Immunol, 187, 3878, 10.4049/jimmunol.1002780 Pellegatti, 2011, P2X7 receptor drives osteoclast fusion by increasing the extracellular adenosine concentration, FASEB J, 25, 1264, 10.1096/fj.10-169854 Di Virgilio, 1989, Responses of mouse lymphocytes to extracellular adenosine 5′-triphosphate (ATP). Lymphocytes with cytotoxic activity are resistant to the permeabilizing effects of ATP, J Immunol, 143, 1955 Zanovello, 1990, Responses of mouse lymphocytes to extracellular ATP. II. Extracellular ATP causes cell type-dependent lysis and DNA fragmentation, J Immunol, 145, 1545 Baricordi, 1996, An ATP-activated channel is involved in mitogenic stimulation of human T lymphocytes, Blood, 87, 682, 10.1182/blood.V87.2.682.bloodjournal872682 Romagnoli, 2008, The P2X7 receptor as a therapeutic target, Expert Opin Ther Targets, 12, 647, 10.1517/14728222.12.5.647 Arulkumaran, 2011, A potential therapeutic role for P2X7 receptor (P2X7R) antagonists in the treatment of inflammatory diseases, Expert Opin Investig Drugs, 20, 897, 10.1517/13543784.2011.578068 Yang, 2015, Inflammasomes and human autoimmunity: a comprehensive review, J Autoimmun, 61, 1, 10.1016/j.jaut.2015.05.001 Kirou, 2005, Activation of the interferon-alpha pathway identifies a subgroup of systemic lupus erythematosus patients with distinct serologic features and active disease, Arthritis Rheum, 52, 1491, 10.1002/art.21031 Nagata, 2010, Autoimmunity and the clearance of dead cells, Cell, 140, 619, 10.1016/j.cell.2010.02.014 Kruse, 2010, Inefficient clearance of dying cells in patients with SLE: anti-dsDNA autoantibodies, MFG-E8, HMGB-1 and other players, Apoptosis, 15, 1098, 10.1007/s10495-010-0478-8 Sun, 2013, Immune complexes activate human endothelium involving the cell-signaling HMGB1-RAGE axis in the pathogenesis of lupus vasculitis, Lab Invest, 93, 626, 10.1038/labinvest.2013.61 Miao, 2011, Caspase-1-induced pyroptotic cell death, Immunol Rev, 243, 206, 10.1111/j.1600-065X.2011.01044.x Garcia-Romo, 2011, Netting neutrophils are major inducers of type I IFN production in pediatric systemic lupus erythematosus, Sci Transl Med, 3, 73ra20, 10.1126/scitranslmed.3001201 Brinkmann, 2012, Neutrophil extracellular traps: is immunity the second function of chromatin?, J Cell Biol, 198, 773, 10.1083/jcb.201203170 Pisetsky, 2014, The complex role of DNA, histones and HMGB1 in the pathogenesis of SLE, Autoimmunity, 47, 487, 10.3109/08916934.2014.921811 Magna, 2015, The role of cell death in the pathogenesis of SLE: is pyroptosis the missing link?, Scand J Immunol, 82, 218, 10.1111/sji.12335 Perry, 2011, Murine models of systemic lupus erythematosus, J Biomed Biotechnol, 2011, 271694, 10.1155/2011/271694 Theofilopoulos, 1985, Murine models of systemic lupus erythematosus, Adv Immunol, 37, 269, 10.1016/S0065-2776(08)60342-9 Watson, 1992, Genetic analysis of MRL-lpr mice: relationship of the Fas apoptosis gene to disease manifestations and renal disease-modifying loci, J Exp Med, 176, 1645, 10.1084/jem.176.6.1645 Subramanian, 2006, A Tlr7 translocation accelerates systemic autoimmunity in murine lupus, Proc Natl Acad Sci U S A, 103, 9970, 10.1073/pnas.0603912103 Satoh, 1995, Anti-nuclear antibody production and immune-complex glomerulonephritis in BALB/c mice treated with pristane, Proc Natl Acad Sci U S A, 92, 10934, 10.1073/pnas.92.24.10934 Zhao, 2013, P2X7 blockade attenuates murine lupus nephritis by inhibiting activation of the NLRP3/ASC/caspase 1 pathway, Arthritis Rheum, 65, 3176, 10.1002/art.38174 Taylor, 2009, P2X7 deficiency attenuates renal injury in experimental glomerulonephritis, J Am Soc Nephrol, 20, 1275, 10.1681/ASN.2008060559 Le Gall, 2012, Loss of P2X7 receptor plasma membrane expression and function in pathogenic B220+ double-negative T lymphocytes of autoimmune MRL/lpr mice, PLoS One, 7, e52161, 10.1371/journal.pone.0052161 Turner, 2007, Increased expression of the pro-apoptotic ATP-sensitive P2X7 receptor in experimental and human glomerulonephritis, Nephrol Dial Transplant, 22, 386, 10.1093/ndt/gfl589 Kahlenberg, 2014, An essential role of caspase 1 in the induction of murine lupus and its associated vascular damage, Arthritis Rheumatol, 66, 152, 10.1002/art.38225 Morse, 2016, Caspase-1 is required for maintenance of marginal zone B cells in pristane-induced lupus, Lupus, 25, 81, 10.1177/0961203315606982 Cigni, 2014, Interleukin 1, interleukin 6, interleukin 10, and tumor necrosis factor alpha in active and quiescent systemic lupus erythematosus, J Investig Med, 62, 825, 10.2310/JIM.0000000000000085 Voronov, 2006, IL-1 beta-deficient mice are resistant to induction of experimental SLE, Eur Cytokine Netw, 17, 109 Chung, 2009, Critical regulation of early Th17 cell differentiation by interleukin-1 signaling, Immunity, 30, 576, 10.1016/j.immuni.2009.02.007 Chen, 2012, The potential role of Th17 cells and Th17-related cytokines in the pathogenesis of lupus nephritis, Lupus, 21, 1385, 10.1177/0961203312457718 Li, 2014, IL-33 neutralization suppresses lupus disease in lupus-prone mice, Inflammation, 37, 824, 10.1007/s10753-013-9802-0 Tucci, 2008, Glomerular accumulation of plasmacytoid dendritic cells in active lupus nephritis: role of interleukin-18, Arthritis Rheum, 58, 251, 10.1002/art.23186 Hu, 2010, Expressions of IL-18 and its binding protein in peripheral blood leukocytes and kidney tissues of lupus nephritis patients, Clin Rheumatol, 29, 717, 10.1007/s10067-010-1386-6 Calvani, 2004, Up-regulation of IL-18 and predominance of a Th1 immune response is a hallmark of lupus nephritis, Clin Exp Immunol, 138, 171, 10.1111/j.1365-2249.2004.02588.x Migliorini, 2010, Serum and urinary levels of IL-18 and its inhibitor IL-18BP in systemic lupus erythematosus, Eur Cytokine Netw, 21, 264 Wang, 2008, Evidence for a pathogenetic role of interleukin-18 in cutaneous lupus erythematosus, Arthritis Rheum, 58, 3205, 10.1002/art.23868 Kahlenberg, 2011, Inflammasome activation of IL-18 results in endothelial progenitor cell dysfunction in systemic lupus erythematosus, J Immunol, 187, 6143, 10.4049/jimmunol.1101284 Kahlenberg, 2013, Neutrophil extracellular trap-associated protein activation of the NLRP3 inflammasome is enhanced in lupus macrophages, J Immunol, 190, 1217, 10.4049/jimmunol.1202388 Elssner, 2004, A novel P2X7 receptor activator, the human cathelicidin-derived peptide LL37, induces IL-1 beta processing and release, J Immunol, 172, 4987, 10.4049/jimmunol.172.8.4987 De, 2000, LL-37, the neutrophil granule- and epithelial cell-derived cathelicidin, utilizes formyl peptide receptor-like 1 (FPRL1) as a receptor to chemoattract human peripheral blood neutrophils, monocytes, and T cells, J Exp Med, 192, 1069, 10.1084/jem.192.7.1069 van der Does, 2010, LL-37 directs macrophage differentiation toward macrophages with a proinflammatory signature, J Immunol, 185, 1442, 10.4049/jimmunol.1000376 Lai, 2011, LL37 and cationic peptides enhance TLR3 signaling by viral double-stranded RNAs, PLoS One, 6, e26632, 10.1371/journal.pone.0026632 Lande, 2011, Neutrophils activate plasmacytoid dendritic cells by releasing self-DNA-peptide complexes in systemic lupus erythematosus, Sci Transl Med, 3, 73ra19, 10.1126/scitranslmed.3001180 Villanueva, 2011, Netting neutrophils induce endothelial damage, infiltrate tissues, and expose immunostimulatory molecules in systemic lupus erythematosus, J Immunol, 187, 538, 10.4049/jimmunol.1100450 Tomasinsig, 2008, The human cathelicidin LL-37 modulates the activities of the P2X7 receptor in a structure-dependent manner, J Biol Chem, 283, 30471, 10.1074/jbc.M802185200 Hakkim, 2010, Impairment of neutrophil extracellular trap degradation is associated with lupus nephritis, Proc Natl Acad Sci U S A, 107, 9813, 10.1073/pnas.0909927107 Denny, 2010, A distinct subset of proinflammatory neutrophils isolated from patients with systemic lupus erythematosus induces vascular damage and synthesizes type I IFNs, J Immunol, 184, 3284, 10.4049/jimmunol.0902199 Asgari, 2013, C3a modulates IL-1beta secretion in human monocytes by regulating ATP efflux and subsequent NLRP3 inflammasome activation, Blood, 122, 3473, 10.1182/blood-2013-05-502229 Auger, 2005, A role for mitogen-activated protein kinase(Erk1/2) activation and non-selective pore formation in P2X7 receptor-mediated thymocyte death, J Biol Chem, 280, 28142, 10.1074/jbc.M501290200 Kawano, 2012, Regulation of P2X7-dependent inflammatory functions by P2X4 receptor in mouse macrophages, Biochem Biophys Res Commun, 420, 102, 10.1016/j.bbrc.2012.02.122 Toki, 2015, Extracellular ATP induces P2X7 receptor activation in mouse Kupffer cells, leading to release of IL-1beta, HMGB1, and PGE2, decreased MHC class I expression and necrotic cell death, Biochem Biophys Res Commun, 458, 771, 10.1016/j.bbrc.2015.02.011 Magna, 2014, The role of HMGB1 in the pathogenesis of inflammatory and autoimmune diseases, Mol Med, 20, 138, 10.2119/molmed.2013.00164 Antoine, 2014, A systematic nomenclature for the redox states of high mobility group box (HMGB) proteins, Mol Med, 20, 135, 10.2119/molmed.2014.00022 Park, 2004, Involvement of toll-like receptors 2 and 4 in cellular activation by high mobility group box 1 protein, J Biol Chem, 279, 7370, 10.1074/jbc.M306793200 Xu, 2014, Macrophage endocytosis of high-mobility group box 1 triggers pyroptosis, Cell Death Differ, 21, 1229, 10.1038/cdd.2014.40 Mitroulis, 2011, Neutrophil extracellular trap formation is associated with IL-1beta and autophagy-related signaling in gout, PLoS One, 6, e29318, 10.1371/journal.pone.0029318 Benihoud, 2002, Unusual expression of LINE-1 transposable element in the MRL autoimmune lymphoproliferative syndrome-prone strain, Oncogene, 21, 5593, 10.1038/sj.onc.1205730 Morel, 2010, Genetics of SLE: evidence from mouse models, Nat Rev Rheumatol, 6, 348, 10.1038/nrrheum.2010.63 Elliott, 2005, The P2X7 receptor is a candidate product of murine and human lupus susceptibility loci: a hypothesis and comparison of murine allelic products, Arthritis Res Ther, 7, R468, 10.1186/ar1699 Buell, 1998, Gene structure and chromosomal localization of the human P2X7 receptor, Recept Channels, 5, 347 Nath, 2004, Linkage at 12q24 with systemic lupus erythematosus (SLE) is established and confirmed in Hispanic and European American families, Am J Hum Genet, 74, 73, 10.1086/380913 Chen, 2013, Association of P2X7R gene polymorphisms with systemic lupus erythematosus in a Chinese population, Mutagenesis, 28, 351, 10.1093/mutage/get007 Forchap, 2008, P2X7 gene polymorphisms do not appear to be a susceptibility gene locus in sporadic cases of systemic lupus erythematosus, Tissue Antigens, 72, 487, 10.1111/j.1399-0039.2008.01136.x Portales-Cervantes, 2010, Expression and function of the P2X(7) purinergic receptor in patients with systemic lupus erythematosus and rheumatoid arthritis, Hum Immunol, 71, 818, 10.1016/j.humimm.2010.05.008 Conti, 2013, Biological therapies in rheumatic diseases, Clin Ter, 164, e413 McCoy, 2016, Targeting the inflammasome in rheumatic diseases, Transl Res, 167, 125, 10.1016/j.trsl.2015.06.006